StonvexLoading…
StonvexStonvexStonvexCore line items from ARCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $82.03M | $152.31M | $166.80M | $206.00M |
Operating Income | $-76.26M | $-95.67M | $-78.20M | $12.18M |
Net Income | $-65.78M | $-80.94M | $-29.73M | $9.35M |
EPS (Diluted) | $-2.40 | $-3.00 | $-1.12 | $0.35 |
Total Assets | $271.15M | $344.07M | $429.40M | $450.39M |
Total Liabilities | $57.16M | $103.09M | $150.89M | $180.07M |
Cash & Equivalents | $230.91M | $237.03M | $292.00M | $391.88M |
Free Cash Flow OCF − CapEx | $-74.50M | $-60.40M | $-21.00M | $24.27M |
Shares Outstanding | 28.41M | 27.00M | 26.83M | 26.55M |